ドナー膵臓の保存改善のためのグローバル利用・レジストリデータベース(GUARDIAN-PANCREAS)
ドナー膵臓の改善された保存のためのグローバル利用およびレジストリデータベース(GUARDIAN-PANCREAS)
The primary objective of this study is to collect real-world clinical performance data to assess the clinical outcomes of patients receiving pancreas transplants using donor pancreata transported via the PancreasPak system. These results will be compared to standard of care outcomes, as well as other preservation methods.
調査の概要
詳細な説明
GUARDIAN-PANCREAS is a post-market, observational registry of adult transplant recipient patients whose donor pancreas was preserved and transported within the PancreasPak. The data is being collected retrospectively from medical records of patients already transplanted before the initiation of the registry and any new patients who meet the eligibility criteria.
About 1000 subjects meeting the study inclusion and exclusion criteria will be enrolled into the study at about 15 clinical sites.
Candidates that fit the eligibility criteria and have had their donor pancreas transported with a Paragonix product or a standard of care method can be enrolled. The baseline characteristics and outcomes of the two groups will be compared.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Amanda Schreiner
- 電話番号:22 781-428-4153
- メール:aschreiner@paragonixtechnologies.com
研究連絡先のバックアップ
- 名前:Julia Hersum
- 電話番号:4 781-428-4153
- メール:julia@paragonixtechnologies.com
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients who have received a pancreas transplant at centers that use the PancreasPak device.
説明
Inclusion Criteria:
• Adult or pediatric recipients of pancreas alone, simultaneous pancreas-kidney, or pancreas after kidney transplant
Exclusion Criteria:
- Donor pancreata that do not meet institutional clinical requirements for transplantation
- Simultaneous pancreas-kidney transplant recipients who received donor organs from multiple donors
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:RETROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
PancreasPak patient
Patients whose donor pancreas was transported with the PancreasPak device. |
The PancreasPak Donor Preservation System is a FDA cleared and CE-marked medical device intended to be used for the static hypothermic preservation of donor pancreata during transportation and eventual transplantation using cold preservation solutions indicated for use in donor pancreata transplantation. The intended organ preservation time for the PancreasPak system is up to 21 hours. |
|
Standard method patients
Patients whose donor pancreas was transported with a method other than the PancreasPak device. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Graft dysfunction
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who experience graft dysfunction post-transplant. |
Post-transplant through 1 year post-transplant
|
|
Pancreatitis
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who experience pancreatitis post-transplant. |
Post-transplant through 1 year post-transplant
|
|
Primary Non-Function
時間枠:Post-transplant through 7 days post-transplant
|
The percentage of subjects in each cohort who primary non-function post transplantation. |
Post-transplant through 7 days post-transplant
|
|
Length of Hospital Stay
時間枠:1 year
|
How many days the patients stays in the hospital post-transplant. |
1 year
|
|
Surgical Complications
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who experience surgical complications. |
Post-transplant through 1 year post-transplant
|
|
Insulin Dependence
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who experience insulin dependence post-transplant. |
Post-transplant through 1 year post-transplant
|
|
Graft Failure
時間枠:Post-transplant through 1 year post
|
The percentage of subjects in each cohort who develop graft failure post-transplant. |
Post-transplant through 1 year post
|
|
Survival
時間枠:Post-transplant through 1 year post
|
The percentage of subjects in each cohort who survive through 1 year post-transplant. |
Post-transplant through 1 year post
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Length of ICU Stay
時間枠:1 year
|
How many days the patient stayed in the ICU post-transplant. |
1 year
|
|
Interventions for Anastomotic Complications
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who required interventions due to anastomotic complications. |
Post-transplant through 1 year post-transplant
|
|
Intervention for Vascular Complications
時間枠:Post-transplant through 1 year-post transplant
|
The percentage of subjects in each cohort who required interventions due to vascular complications. |
Post-transplant through 1 year-post transplant
|
|
Medications
時間枠:Post-transplant through 1 year post-transplant
|
The percentage of subjects in each cohort who required the use of various medications. |
Post-transplant through 1 year post-transplant
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。